It has recently been shown that TRPA1 contributes to migraine-associated hypersensitivity, since the TRPA1 antagonist, ADM_12, prevented the nitroglycerine-induced hyperalgesia in both the acute and chronic migraine models [46]. Here, TRPA1 is linked to migraine disorder.